Emre Dirican

Dr. Emre Dirican

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2022 in Primary Health Care Research & Development
Verified
Journal Article
Open access
PDF file
EDEmre Dirican
Emre Dirican
TBTayibe Bal
Tayibe Bal
Background: It is unclear, whether the initial disease severity may help to predict which COVID-19 patients at risk of developing persistent symptoms. Aim: The aim of this study was to examine whether the initial disease severity affects the risk of persistent symptoms in post-acute COVID-19 syndrome and long COVID. Methods: A systematic search was conducted using PUBMED, Google Scholar, EMBASE, and ProQuest databases to identify eligible articles published after January 2020 up to and including 30 August 2021. Pooled odds ratio (OR) and confidence intervals (CIs) were calculated using random effects meta-analysis. Findings: After searching a total of 7733 articles, 20 relevant observational studies with a total of 7840 patients were selected for meta-analysis. The pooled OR for persistent dyspnea in COVID-19 survivors with a severe versus nonsevere initial disease was 2.17 [95%CI 1.62 to 2.90], and it was 1.33 [95%CI 0.75 to 2.33] for persistent cough, 1.30 [95%CI 1.06 to 1.58] for persistent fatigue, 1.02 [95%CI 0.73 to 1.40] for persistent anosmia, 1.22 [95%CI 0.69 to 2.16] for persistent chest pain, and 1.30 [95%CI 0.93 to 1.81] for persistent palpitation. Conclusions: Contrary to expectations, we did not observe an association between the initial COVID-19 disease severity and common persistent symptoms except for dyspnea and fatigue. In addition, it was found that being in the acute or prolonged post-COVID phase did not affect the risk of symptoms. Primary care providers should be alert to potential most prevalent persistent symptoms in all COVID-19 survivors, which are not limited to patients with critical–severe initial disease.

29 January 2021 in Dermatology Practical & Conceptual
Verified
Journal Article
Open access
PDF file
GSGamze Serarslan
Gamze Serarslan
ÖKÖzlem Makbule Kaya
Özlem Makbule Kaya
EDEmre Dirican
Emre Dirican
Citation: Serarslan G, Makbule Ö, Dirican E. Scale and pustule on dermoscopy of rosacea: a diagnostic clue for Demodex Species. Dermatol Pract Concept. 2021;11(1):e2021139. DOI: https://doi.org/10.5826/dpc.1101a139 Accepted: September 8, 2020; Published: January 29, 2021 Copyright: ©2021 Serarslan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License BY-NC-4.0, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited. Funding: None. Competing interests: The authors have no conflicts of interest to disclose. Authorship: All authors have contributed significantly to this publication. Corresponding Author: Gamze Serarslan, MD, Mustafa Kemal University, Faculty of Medicine, Department of Dermatology, 31100 Hatay, Turkey. Email: gserarslan@hotmail.com Background: Demodex mites are highly found in the skin of patients with rosacea.The diagnosis of Demodex can be made by standardized skin surface biopsy. Dermoscopy is a tool used in the noninvasive diagnosis of various dermatological diseases. Objectives: To determine whether dermoscopic features of demodicosis are associated with the result of standardized skin surface biopsy in patients with rosacea and to compare dermoscopic features of rosacea in Demodex-positive and negative samples and Demodex type. Methods: A total of 30 patients (7 male, 23 female) were included in the study. Dermoscopic examination was performed on both the clinically most severely affected areas and adjacent healthy skin. The skin surface biopsy sample was taken from the same place from where the dermoscopic image was taken. Results: A total of 83 (lesion n = 60, non-lesion n = 23) areas were evaluated. Demodex was detected in 60.2% (n = 50) of the samples. Half of these samples revealed only Demodex folliculorum, and the remaining half revealed D folliculorum and Demodex brevis. Of theDemodex-positive samples, 88% had Demodex tails (P =0.001) and68% Demodex follicular openings (P = 0.002) on dermoscopy. In D folliculorum+D brevis-positive samples, the rate of scale and pustule was higher than D folliculorum-positive samples (P = 0.017 and P = 0032,respectively). Conclusions: The sensitivity and specificity of Demodex tail are higher than Demodex follicular opening and scale and pustule detection with dermoscopy and may indicate the coexistence of both D folliculorum and D brevis. Keywords : Demodex folliculorum, Demodex brevis, rosacea, dermoscopy This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

1 December 2020 in Turkish Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
TBTayibe Bal
Tayibe Bal
SDSERDAR DOGAN
SERDAR DOGAN
MCMehmet Cabalak
Mehmet Cabalak
EDEmre Dirican
Emre Dirican
Objectives: We aimed to evaluate the ability of lymphocyte-C-reactive protein ratio (LCR) to discriminate between different levels of severity of COVID-19 disease. Methods: This retrospective observational single-center study was performed on 61 confirmed (PCR positive) COVID-19 patients between March and June 2020. The study population was separated into three groups: mild/moderate (n=24), severe (n=25) and critically ill (n=12). The optimal cut-off values of the LCR and neutrophil-to-lymphocyte ratio (NLR) in discriminating between patients with different severity levels were calculated by applying the receiver operating curve (ROC) analysis. Results: At baseline, the LCR decreased significantly across the three severity groups (mild/moderate > severe > critically ill). ROC analysis showed that a mean LCR of 43.21 was the cut-off value which best discriminated patients with the critically ill disease from severe patients (sensitivity: 84% and specificity: 69%). The discriminative performance of LCR (ROC AUC 0.820) was better than that of NLR (0.751) in this regard. LCR, unlike NLR was able to distinguish severe patients from mild/moderate patients, with a cut off value of 458.19 (sensitivity: 80% and specificity: 45%). Conclusion: LCR was observed to be able to distinguish COVID-19 infected patients of different severity (mild/moderate, severe and critically ill) and was superior to NLR in this regard.

15 August 2023 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
RCRasim Eren Cankurtaran
Rasim Eren Cankurtaran
YGYasin Celal Gunes
Yasin Celal Gunes
EDEmre Dirican
Emre Dirican
OAOktay ALGIN
Oktay ALGIN
DCDamla Cankurtaran
Damla Cankurtaran
ÖYÖykü Tayfur Yürekli
Öykü Tayfur Yürekli
Background: Limited research has examined the clinical consequences of sarcopenia and myosteatosis in Crohn’s disease. This study aimed to determine the prevalence, risk factors, and effects of sarcopenia and myosteatosis on prognostic outcomes in Crohn’s disease patients who underwent magnetic resonance enterography. Materials and Methods: This retrospective observational study included 116 Crohn’s disease patients who underwent magnetic resonance enterography between January 2015 and August 2021. Skeletal muscle index was the ratio of the cross-sectional area of skeletal muscles at the L3 vertebral level to the square of the neck in cross-sectional imaging. Sarcopenia was defined as skeletal muscle index <38.5 cm2/m2 in women and <52.4 cm2/m2 in men. Myosteatosis was considered positive if the ratio of the mean signal intensity of the psoas muscle to the mean signal intensity of the cerebrospinal fluid was above 0.107. Results: Among the negative results in the post-procedure follow-up of the patients, a significant increase was observed in the sarcopenia group regarding abscess and the need for surgery (P < .05). Anti-tumor necrosis factor initiation was found to be significantly higher in the follow-up than in patients without myosteatosis (P = .029). In the multivariate model established with these variables, the presence of sarcopenia in the surgical follow-up was odds ratio = 5.34 (CI: 1.02-28.03, P = .047) and was found to be significantly associated with the increased risk. Conclusions: The presence of myosteatosis and sarcopenia detected in magnetic resonance enterography may be a harbinger of negative outcomes in Crohn’s disease patients. Nutritional support should be provided to these patients with the potential to alter the course of the disease. Cite this article as: Cankurtaran RE, Güneş YC, Dirican E, Algın O, Cankurtaran D, Tayfur Yürekli Ö. Sarcopenia and myosteatosis assessed by magnetic resonance enterography may predict negative outcomes in patients with Crohn’s disease. Turk J Gastroenterol. 2023;34(8):839-849.


1 January 2020 in Advances in Dermatology and Allergology
Verified
Journal Article
Open access
PDF file
OKOzlem Makbule Kaya
Ozlem Makbule Kaya
GSGamze Serarslan
Gamze Serarslan
EDEmre Dirican
Emre Dirican
Introduction Cutaneous leishmaniasis (CL) is a skin disease affecting all ages but especially children. Cutaneous leishmaniasis exists in Turkey, and, especially together with emigration from Syria to Turkey in recent years due to the civil war in Syria, the incidence of the disease has...